islets 16 allograft transplantations after portal venous immunization with donor spleen cells, and in heart 22 and peripheral nerve 8 allograft transplantations after the same pretreatment with UVB-irradiated donor splenocytes. It is not known whether pretreatment with a portal venous administration of UVB-modified spleen cells will confer a beneficial effect on the subsequent transplantation of xenogeneic cells into the brain. In the present study, we examined the therapeutic effects of dopamine-producing xenografts following portal venous immunization of UVB-irradiated xenogeneic donor spleen cells in an established PD rat model. 17, 18, 37, 42 
Materials and Methods

Animal Preparation
Adult female Fischer 344 rats, each weighing 200 to 250 g at the beginning of the experimental procedures, received an intraperitoneal injection of chloral hydrate (350 mg/kg) dissolved in 0.9% (wt/ vol) NaCl to induce anesthesia and were placed in a stereotactic frame. The dopamine-innervated striatum was unilaterally lesioned by administering injections of 6-OHDA (3 mg/ml in 0.2 mg/ml L-ascorbate/saline) into the right median forebrain bundle. The coordinates selected for injection of 2 l of 6-OHDA were the following: AP Ϫ4 mm, ML Ϫ0.8 mm, V Ϫ8 mm, and TB ϩ3. 4 . The coordinates selected for injection of 2.5 l of 6-OHDA were the following: AP Ϫ4.4 mm, ML Ϫ1.2 mm, V Ϫ7.8 mm, and TB Ϫ2.3 mm. The animals received subcutaneous injections of 0.25 mg/kg apomorphine at 2-week intervals, after which the number of 360r otations that each rat made during a 1-hour period was counted. Thirty animals that turned at a rate of seven or more rotations per minute were chosen for the study. Splenocytes obtained from B6/ D2 F1 and C3H/HeN mice (10-week-old females) were used for portal venous immunization.
Experimental Groups
The animals were divided into three groups. Group 1 received two 2-l injections of saline into the dopamine-denervated striatum; Group 2 received two 2-l injections of a xenograft cell suspension; and Group 3 was given a single portal venous dose of UVB-irradiated B6/D2 F1 splenocytes 7 days before receiving two 2-l injections of a xenograft cell suspension.
Preparation and Transplantation of Xenografts
We selected cells from a catecholaminergic cell line established from a CNS tumor that arose in a transgenic B6/D2 F1 mouse carrying wild-type SV40 T antigen under the transcriptional control of a rat THase promoter, the CATH.a cell line. 40 The CATH.a cells were maintained in RPMI-1640 medium supplemented with 8% horse serum and 4% fetal bovine serum at 37˚C in a humidified atmosphere of 5% CO 2 in air. The cells were washed twice with 0.01 M PBS, pH 7.4, following which they were suspended in PBS at a concentration of 4 ϫ 10 7 cells/ml. Animals in Groups 2 and 3 received two 2-l injections of this xenograft cell suspension into the dopamine-denervated striatum (coordinates were set as follows: AP ϩ0.7 mm, ML Ϫ2.3 mm and ϩ3.2 mm, V Ϫ4.5 mm, and TB 0 mm).
Preparation of UVB-Irradiated Donor Cellular Antigen
Spleens were harvested from B6/D2 F1 mice after chloral hydrate (350 mg/kg) had been intraperitoneally administered to induce anesthesia. The spleens were passed through a 60-m stainless-steel mesh into RPMI-1640 medium. The spleen cells were then centrifuged at 1500 rpm and resuspended in Tris-buffered ammonium chloride (0.83%) for 2 minutes to lyse the red blood cells. The cells were washed twice and stirred in an open petri dish. A total of 10 J UVB light/m 2 /sec were delivered to the cells for 20 minutes by using two sunlamps. Next, the splenocytes were suspended in saline at a concentration of 4 ϫ 10 7 cells/ml. Cell viability, determined using a trypan-blue exclusion test after UVB exposure, was greater than 97%.
Portal Venous Administration of UVB-Irradiated Donor Antigen
After anesthesia had been induced, the portal vein of the recipient rat was isolated by a midline incision and 500 l of the B6/D2 F1 splenocyte suspension was injected through a 27-gauge needle.
Immunocytochemical Analysis
At 4 and 12 weeks, graft-recipient animals were killed after they completed rotation tests. After deep anesthesia had been induced by an intraperitoneal injection of chloral hydrate (500 mg/kg), the ani- mals received a perfusion of 50 to 60 ml of 0.1 M PBS at room temperature through the ascending aorta with a flow rate of 25 ml/ minute, followed by 250 to 300 ml of ice-cold 4% paraformaldehyde in 0.1 M PBS. The rat brains were removed and postfixed for 8 hours in the same fixative. Following dehydration in 20% sucrose/ 0.1 M PBS, coronal brain sections were cut to a thickness of 12 m on a freezing microtome.
Brain sections were immersed in 3% H 2 O 2 for 15 minutes to quench endogenous peroxidase activity. After the sections were rinsed three times in PBS (10 minutes for each rinse), they were transferred to a 1:500 dilution of primary rabbit anti-mouse THase antibody. Following an overnight incubation at room temperature, sections were rinsed three times in PBS (10 minutes/rinse) and incubated in a 1:200 dilution of biotin-conjugated anti-rabbit IgG raised in goat for 1 hour. Sections were rinsed repeatedly and transferred to an avidin-biotin complex kit/0.1 M PBS for 1 hour. The chromogen used for this procedure was DAB at a concentration of 0.05% in 0.1 M PBS, supplemented with 0.01% H 2 O 2 . After rinsing the sections three times in 0.1 M PBS (10 minutes/rinse), they were mounted on gelatin-coated glass slides and left to dry overnight. The following day, the sections were counterstained with hematoxylin and were dehydrated in ascending concentrations of alcohol, cleared in xylene, and protected with a coverslip.
Cultured CATH.a cells on glass slides were also used for this immunocytochemical investigation following a step of fixation with 4% paraformaldehyde in 0.1 M PBS.
Reverse Transcription Followed by Amplification With PCR
Total RNA was prepared from CATH.a cells by using Trizol reagent. Poly A + mRNA was prepared from total RNA by double purification on oligo dT-latex beads by using standard techniques. First-strand complementary DNA synthesis was conducted using 1 g of poly A + mRNA, 200 U of Moloney murine leukemia virus reverse transcriptase, and 100 ng of random hexameric primers. The RT reaction was performed at 37˚C for 45 minutes and was terminated by heating at 95˚C for 5 minutes. Amplification of GAPDH was used as an internal control for RT-PCR. Primers for THase and GAPDH were added to 5% of the randomly primed RT reaction and 40 rounds of PCR (denaturation at 94˚C for 30 seconds, annealing at 54˚C for 1 minute, and extension at 72˚C for 1 minute) were performed. The actual sequences of the primers for TH and GAPDH were as follows: THase 5Ј primer, 5Ј-CAGGGCTGCTGTCTT-CCTAC-3Ј; THase 3Ј primer, 5Ј-GGGCTGTCCAGTACGTCA-AT-3Ј; GAPDH 5Ј primer, 5Ј-CCATCACCATCTTCCAGGAG-3Ј; GAPDH 3Ј primer, 5Ј-CCTGCTTCACCACCTTCTTG-3Ј. Twenty percent of the amplification reaction was subjected to a 2% agarose gel and the amplified product was visualized by ethidium bromide staining.
Mixed Lymphocyte Culture
Three rats each in Groups 1 and 3 were killed 14 days after transplantation. Spleen cells (10 5 ) from each rat were incubated alone or with stimulator cells (10 5 ) in a microtiter culture plate (200 l of total volume) at initiation of the reaction. As stimulators, 20 Gy-irradiated C3H/HeN or B6/D2 F1 murine splenocytes were used. After a 5-day incubation at 37˚C in a humidified atmosphere of 5% CO 2 in air, the cells were pulsed with 1 Ci of [ The stimulation index was calculated using the following formula: stimulation index = proliferation of rat splenocytes stimulated with irradiated murine splenocytes (cpm)/spontaneous proliferation of rat splenocytes (cpm).
High-Performance Liquid Chromatography
The levels of levodopa and dopamine in the culture medium were analyzed using reverse-phase HPLC with a 4.6 ϫ 150-mm C-18 column and an analyzer.
Statistical Analysis
Rotational behavior was quantified every 2 weeks for 12 weeks.
Net contralateral rotations for each rat were counted and recorded as a percentage of their pretransplantation values. The mean scores for each group at each time point were compared using the Student t-test. Statistics were calculated using commercially available software.
Sources of Supplies and Equipment
The Fischer 344 rats and the B6/D2 F1 and C3H/HeN mice were obtained from Japan SLC (Hamamatsu, Japan). The 6-OHDA was purchased from Sigma Chemical Co. (St. Louis, MO). The primary rabbit anti-mouse THase antibody was acquired from Chemicon International (Temecula, CA) and the biotin-conjugated anti-rabbit IgG raised in goat from Vector Laboratories (Burlingame, CA). The Vectastain ABC (avidin-biotin complex) kit was purchased from Vector Laboratories and the DAB from Wako Chemical (Osaka, Japan). Trizol and Moloney murine leukemia virus RT were obtained from Gibco-BRL (Gaithersburg, MD) and the oligo dT-latex beads from Takara (Ohtsu, Japan). The hexameric primers were supplied by Promega Corp. 
Results
Dopamine Production by CATH.a Cells
Before investigating the effects of CATH.a cell implantation on the circling behavior of lesioned rats, we examined whether these cells, used as xenografts in our experiments, were capable of producing dopamine. As shown in Fig. 1 , mRNA and protein expressions of THase were confirmed by RT-PCR and immunohistochemical staining, respectively. After a 5-day culture of 10 6 cells in a 35-mm-diameter culture dish (3 ml total volume), dopamine and levodopa were detected in the supernatant of CATH.a cell cultures at concentrations of 41.8 Ϯ 0.6 ng/ml and 13.8 Ϯ 0.5 ng/ml, respectively.
Rotational Behavior After Xenograft Transplantation
Rotational scores are shown in Fig. 2 . Rats in Groups 2 and 3 exhibited significantly reduced rotational behavior compared with those in Group 1 (*p Ͻ 0.01, **p Ͻ 0.001 in Fig. 2 ). In addition, rats in Group 3 displayed significantly reduced rotational behavior compared with those in Group 2 ( + p Ͻ 0.001 in Fig. 2) , which was observed throughout the experimental period.
Immunohistological Findings at Graft Sites
Histological examples of graft sites at 4 and 12 weeks after transplantation in Groups 2 and 3 are shown in Fig.  3 . In Group 2, abundant lymphocytes and a few THasepositive cells were found at 4 weeks (Fig. 3A) . The THase-positive cells almost disappeared at 12 weeks, but not the lymphocytes (Fig. 3B) . In Group 3, however, a large number of THase-positive cells were found at 4 weeks (Fig. 3C) and some of them remained at 12 weeks (Fig. 3D) . In Group 1 animals, a slight infiltration of inflammatory cells was found along the needle track at 4 weeks; this had almost disappeared by 12 weeks posttransplantation.
Proliferation of Rat Splenocytes Cocultured With Irradiated Murine Splenocytes
Spleen cells from Group 1 rats responded well to irradiated B6/D2 F1 and C3H/HeN spleen cells (Fig. 4 left) . On the other hand, spleen cells from Group 3 responded well to C3H/HeN spleen cells, but poorly to B6/D2F1 spleen cells (Fig. 4 right) .
Discussion
Transplantation with allogeneic or xenogeneic grafts has potential as a therapeutic approach to replace the function of degenerated brain cells. The use of xenografts may avoid some problems associated with human fetal tissue transplantation, such as low availability and complex ethical issues. In the present study, we used cells from the CATH.a cell line, a dopamine-producing murine CNS tumor cell line, to form a xenograft for transplantation into unilaterally dopamine denervated rats. Dopamine production by the graft has been demonstrated to be critical for the improvement of rotational behavior in PD model rats. Furthermore, neurons differentiated from murine embryonal P19 carcinoma cells have been reported to survive for longer than 12 weeks after grafting without forming tumor masses in the brains of PD model rats that have been immunosuppressed by CsA. 31 In the report in which that was described, the authors stated that no improvement in rotational behavior was observed because of the cells' inability to produce dopamine. Therefore, in the present study, we first examined whether CATH.a cells expressed THase and produced dopamine, even though CATH.a cells have been previously reported to possess biologically active THase and to produce two catecholamines, dopamine and norepinephrine. 40 As shown in Fig. 1 , we confirmed mRNA expression and protein production of THase in the CATH.a cells. Secreted levodopa and dopamine were also detected by HPLC in a supernatant of cultured CATH.a cells. Thus, we speculated that the CATH.a cell line could be a xenograft candidate for use in model rats with PD. As we expected, a significant reduction in rotational behavior was observed in rats with transplanted CATH.a cells.
A transplantation strategy in which xenografts are to be used faces the problem of graft rejection; thus, an efficient immunosuppression therapy is required to obtain longterm survival of the xenograft. Recently, portal venous administration of foreign cells was reported to induce donorspecific immunological tolerance across major, 13, 21, 23, 32, 33, 36, 44 minor, 10 and xenogenic 19 histocompatibility complex barriers. In addition, the presentation of a UVB-modified antigen in the hepatic environment was reported to enhance the induction of donor-specific anergy in vivo. 8, 22, 45 Therefore, we gave the animals a portal venous injection of UVB-irradiated spleen cells to induce a donor-specific immunological tolerance. A better improvement in rotational behavior was achieved in rats that had received a portal venous immunization of UVB-irradiated B6/D2 F1 mouse spleen cells before receiving xenografts of CATH.a cells, compared with those animals that did not receive portal venous immunization. In rats that received such immunosuppressive treatment, a prolonged survival time of xenografts was shown immunohistochemically. For a more strict study, we should have increased the number of animal groups, including rats in which xenografts were transplanted into the brain and saline was administered into the portal vein and those in which saline was administered to the brain and donor lymphocytes were injected into the portal vein. We can, however, conceivably deduce from the present results alone that portal venous administration of xenogeneic donor lymphocytes induced donorspecific immunological tolerance within the brain.
The mechanisms underlying this donor-specific immunological tolerance after portal venous immunization with spleen cells are uncertain. A consensus is developing that clonal anergy in the CD8ϩ T cells of the recipients is induced via preferential activation of Th2-type cells, rather than Th1-type cells, by the hepatic antigen-presenting cells, leading to a predominant production of interleukin 10. 4, 11, 12, 25, 39, 45, 46 Although we did not measure interleukin 10 production in liver-residing lymphocytes or separate the CD8ϩ lymphocytes, we observed donor-specific hyporesponsiveness in spleen cells excised from portal venous preimmunized rats in the mixed lymphocyte cultures when testing the cells' proliferation. Ultraviolet B irradiation has been known to affect donor-host interactions in transplantation models. 5, 15, 24 Ultraviolet B irradiation alters host immune responses by the induction of some specific cytokine production leading to preferential activation of Th2-type cells, 34, 38, 41 and also alters donor immunogenicity by modifying DNA 1, 26 and cell surface antigens including major histocompatibility complex Class II antigen 14 and the complementary pair of adhesion molecules ICAM1/LFA-1. 9 Grafts directly irradiated with UVB light are capable of inducing a donor-specific immunological tolerance. 6, 27 Recently, pretreatment with a photosensitiz- er, verteporfin, also has been reported to prevent rejection of murine neural xenografts transplanted in rats. 20 In a variety of current graft-rejection prevention strategies, CsA is the gold standard. This drug impairs most functions of the immune system and is well known to be associated with side effects such as renal toxicity and bone marrow suppression. We attempted CATH.a cell transplantation concurrent with daily subcutaneous administration of CsA (10 mg/kg body weight) to induce immunological tolerance; however, we observed tumor development in the brain, contrary to a previous observation after transplantation of P19 cells into rat brains. 31 A differentiated variant of CATH.a cells, CAD cells, 35 may have been a more suitable xenograft candidate for the present study, because they do not have the immortalizing oncogene SV40 T antigen, although they maintain the ability to produce dopamine. Viability and immortalization of transplanted xenogeneic cells are major but antithetical issues in the present study. Careful observations for a longer interval will be needed to evaluate the efficacy of portal venous immunization with xenogeneic donor lymphocytes in the induction of immunological tolerance.
Neural xenograft transplantation, that is, transplantation of neural tissue or cells from a different mammalian species into the human brain, may circumvent many of the limitations associated with the use of human fetuses; however, neural transplantation across animal species has been reported to lead to vigorous rejection. 2, 30 We believe that the induction of immunological tolerance used in the present study was an efficient immunosuppressive therapy to control severe rejection of transplanted neural xenografts without serious side effects, even though surgical procedures are required for portal venous administration of xenogeneic lymphocytes. Oral administration of xenogeneic antigen, a noninvasive procedure, as a substitute for portal venous immunization may be a more attractive therapeutic modality for use in inducing antigen-specific immunological tolerance. 
